Variant report
Variant | esv1812144 |
---|---|
Chromosome Location | chr5:177120697-177138298 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-RP11-1026M7.2.1-2 | chr5:177133707-177133886 | ENSG00000249849.1 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10060053 | chr5:177120697-177120698 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs572590308 | chr5:177120760-177120761 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs181932791 | chr5:177120763-177120764 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532332505 | chr5:177120789-177120790 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs550833934 | chr5:177120790-177120791 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371939749 | chr5:177120795-177120796 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs569989236 | chr5:177120796-177120797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs537449121 | chr5:177120799-177120800 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549500569 | chr5:177120819-177120820 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567730294 | chr5:177120820-177120821 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535255620 | chr5:177120829-177120830 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs115797571 | chr5:177120851-177120852 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs4046148 | chr5:177120852-177120853 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs141414649 | chr5:177120922-177120923 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs2878302 | chr5:177120926-177120927 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs557629943 | chr5:177120927-177120928 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575136042 | chr5:177120928-177120929 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs138889123 | chr5:177120957-177120958 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149404176 | chr5:177120970-177120971 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572574386 | chr5:177120988-177120989 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539918458 | chr5:177120993-177120994 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs2334995 | chr5:177121008-177121009 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2334994 | chr5:177121053-177121054 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564772004 | chr5:177121084-177121085 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532322572 | chr5:177121259-177121260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs373486868 | chr5:177121271-177121272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs562753254 | chr5:177121305-177121306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530818085 | chr5:177121321-177121322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs375757279 | chr5:177121350-177121351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567645599 | chr5:177121468-177121469 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs528634121 | chr5:177121542-177121543 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs112191760 | chr5:177121755-177121756 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs111736535 | chr5:177121756-177121757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs368827763 | chr5:177121791-177121792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373488003 | chr5:177121803-177121804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547109625 | chr5:177121945-177121946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs571795676 | chr5:177121964-177121965 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs377603915 | chr5:177122011-177122012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187669208 | chr5:177122018-177122019 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs557380907 | chr5:177122029-177122030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs2650335 | chr5:177122073-177122074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs569498610 | chr5:177122094-177122095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs535865680 | chr5:177122112-177122113 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377046656 | chr5:177122125-177122126 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs559064869 | chr5:177133806-177133807 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs1696909 | chr5:177133829-177133830 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs556599467 | chr5:177133839-177133840 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs575114966 | chr5:177133855-177133856 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs572094399 | chr5:177137414-177137415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs185623057 | chr5:177137424-177137425 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
Autism | 20841430 | CNVD |
Developmental delay | 21147756 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:177117600-177121000 | Weak transcription | K562 | blood |
2 | chr5:177119800-177120800 | Enhancers | HepG2 | liver |
3 | chr5:177119800-177121000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr5:177119800-177121200 | Enhancers | Fetal Lung | lung |
5 | chr5:177120400-177121000 | Enhancers | Left Ventricle | heart |
6 | chr5:177120400-177121000 | Enhancers | Stomach Mucosa | stomach |
7 | chr5:177120600-177121000 | Enhancers | Liver | Liver |
8 | chr5:177120600-177121000 | Enhancers | Duodenum Mucosa | Duodenum |
9 | chr5:177120600-177121000 | Enhancers | Rectal Mucosa Donor 29 | rectum |
10 | chr5:177120800-177121200 | Enhancers | Ovary | ovary |
11 | chr5:177120800-177121200 | Flanking Active TSS | HepG2 | liver |
12 | chr5:177120800-177122000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
13 | chr5:177121000-177121400 | Enhancers | K562 | blood |
14 | chr5:177121200-177122200 | Enhancers | HepG2 | liver |
15 | chr5:177121400-177121600 | Weak transcription | K562 | blood |
16 | chr5:177121600-177122000 | Enhancers | K562 | blood |
17 | chr5:177137400-177142000 | Weak transcription | Primary T helper naive cells fromperipheralblood | blood |